View Older Stories View More Recent Stories
-
Eco-stim Energy Solutions (ESES) Announces $30M Common Offering
-
Eco-Stim Energy Solutions Announces Public Offering of Shares of Common Stock
-
Eco-Stim Energy Solutions Announces Public Offering of Shares of Common Stock
-
ROTH Capital Partners to Host Cleantech Day in London on June 25, 2015
-
Roth Capital Downgrades Insite Vision (INSV) to Neutral
-
BioCardia (BCDA) Files $57.5M Common Stock IPO
-
Spark Therapeutics to Participate in Two International Conferences in London in June
-
Spark Therapeutics to Participate in Two International Conferences in London in June
-
Roth Capital Starts Quest Resource (QRHC) at Buy
-
BioCardia, Inc. Files Registration Statement for Proposed Initial Public Offering
-
ROTH Capital Partners to Host Healthcare Day In London on June 24, 2015
-
Roth Capital Remains Bullish Following Motorcar Parts of America (MPAA) FQ4 Beat
-
Roth Capital Starts Trevena (TRVN) at Buy, $14.50 PT
-
Roth Capital Raises Price Target on Iradimed Corp. (IRMD) After traveling with Management
-
Pace of ECCO-50 Development in OA Patients Remains Robust; Roth Affirms Cytori Therapeutics (CYTX) at 'Buy'
-
Redhill Biopharma (RDHL) PT Raised to $30 at Roth Capital
-
Bio Blast Pharma (ORPN) PT Raised to $25 at Roth Capital
-
Galena Biopharma's (GALE) GALE-401 Phase 2 Shows Potential Advantage of IR formulation; Roth Affirms at 'Buy'
-
Consolidated Water Co. Ltd. to Participate in ROTH Capital Partners "Cleantech Day" on June 25, 2015 in London
-
Roth Capital Raises Price Target on Sunesis Pharmaceuticals (SNSS) Following EHA Presentation
-
bluebird bio (BLUE) Bullish Stance Reiterated at Roth Capital Following HGB-205 Study Data
-
Challenged Athletes Foundation Raises More Than $2 Million at Ninth Annual Gala in New York City
-
Notable 52-Week Highs and Lows 6/12: (FOLD) (KFY) (AGEN) High; (GMCR) (LF) (ZQL) Low
-
Positive Trend for MEI Pharma's (MEIP) Pracinostat in Frontline AML Continues; Roth Affirms at 'Neutral'
-
Promacta Receives FDA Approval for Children with ITP; Roth Raffirms Ligan Pharma (LGND) at 'Buy' (NVS)
-
Roth Capital Cuts Price Target on LeapFrog Enterprises (LF) Following EPS Miss
-
ContraFect Corporation Announces $20,000,000 Private Placement
-
Notable 52-Week Highs and Lows 6/11: (C) (LLY) (MW) High; (CHK) (ZQK) (MARA) Low
-
Biotie Therapies (BITI) IPO Opens Up 22%
-
Pre-Open Stock Movers 06/11: (ASTI) (BOX) (KKD) Higher; (GLP) (DRNA) (TUBE) Lower (more...)
-
Roth Capital Remains Bullish on Krispy Kreme Doughnuts (KKD) Following 1Q16
-
Roth Capital Starts PlasmaTech Bio (PTBI) at Buy, $16 PT
-
Roth Capital Cuts Price Target on Quicksilver (ZQK) Following 2Q15 Results
-
Roth Sees Peregrine Pharma (PPHM) Entering Key Execution Phase; Affirms at 'Buy'
-
Roth Capital Raises Price Target on Radiant Logistics (RLGT) Following Announced Acquisitions
-
RCA HGB-208 Pushback Seen as 'Modest Stumble', Roth Capital Says
-
Roth Capital Remains Bullish on Craft Brewers Alliance (BREW) Following Investor Meetings
-
Notable Analyst Rating Changes 6/9: (ECR) (AMED) (NBL) Upgraded; (CTXS) (ALV) (AKAM) Downgraded
-
Draft Guidance From FDA 'Potentially Supportive' of Sarepta (SRPT) Accelerated Approval, Roth Capital Says
-
Roth Capital Reiterates Bullish View on bluebird bio (BLUE) Ahead of EHA Data
-
Roth Capital Upgrades QLT Inc (QLTI) to Buy
-
Ballard Power (BLDP) $10M China Bus Deal Lays Foundation for Similar Deals, Roth Capital Says
-
InSite Vision to Merge With Canadian Biotechnology Company QLT
-
Roth Capital 'Impressed' with '6972 Safety Profile; Affirms Ligand Pharma (LGND) at 'Buy'
-
Enphase Energy to Participate at Upcoming ROTH Capital Partners Conference
-
Roth Capital Reiterates Buy Ahead of Vical (VICL) HSV-2 Data
-
Cachet Financial Solutions Completes $4.4 Million Private Placement
-
Sarepta Therapeutic (SRPT) Highlighted at Roth Capital as DMD-Sector Heats Up Into Summer
-
Roth Capital Trims PT on Yingli Green Energy (YGE) to $1.30 Following Q1 Report
-
Atossa Genetics (ATOS) Announces $6.22 Common Stock, Warrants Direct Placement

